Pyroxamide

DB12847InvestigationalSmall molecule

Pyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others.

Formula / weight: C₁₃H₁₉N₃O₃ · 265.313 g/mol (avg)

Resolves to

Compound

UNII12N86DSS23CAS382180-17-8ChEMBLCHEMBL353581ChEBI93953PubChem4996

Structure

InChIKeyPTJGLFIIZFVFJV-UHFFFAOYSA-NSMILESONC(=O)CCCCCCC(=O)NC1=CN=CC=C1

Targets

Q13547HDAC1

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pyroxamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account